- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05472454
The Ready-to-Eat Meals for Cardiovascular Health Study (REACH)
June 1, 2026 updated by: Pablo Monsivais, Washington State University
The Ready-to-EAt Meals for Cardiovascular Health (REACH) Study
The proposed project explores the acceptability and health benefits of ready-to-eat (RTE) meals based on the Dietary Approaches to Stop Hypertension (DASH) eating plan.
The researchers have developed 14 recipes following the DASH eating plan, which is recommended for the prevention of cardiovascular disease (CVD).
The prepackaged meals will be processed using Washington State University (WSU) microwave technologies to ensure food safety.
In this pilot study, a sample of 30 participants will be recruited by to study the impact of the DASH meals on blood pressure.
All meals will be provided to participants, who will consume the meals daily over a period of 4 weeks.
Daily and weekly monitoring of participants (blood pressure and weight) will allow us to gain a scientific understanding on the preventive power of healthy diets in lowering blood pressure and reducing CVD risk.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Spokane, Washington, United States, 99202
- Washington State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male or female
- 18 years old or older
- BMI 18.5-40.0 kg/m2
- Daily access to working internet, microwave, refrigerator, and freezer
- English fluency
Exclusion Criteria:
- Regular use of drugs that affect BP, including weight loss medications
- Diagnosed hypertension OR systolic BP >130 and/or diastolic BP >80
- Diagnosis of any hypotensive disorders OR systolic BP <100 and/or diastolic BP<65
- Dietary restrictions, including allergy/intolerances
- Presence or history of diabetes
- Previous cardiac event, congestive heart failure, or angina
- Weight loss or gain>15lb in previous 3 months
- Following a diet to increase or decrease body weight
- Cancer diagnosis or treatment in past 2 years
- ≥14 alcoholic drinks/week for men; ≥ 7 alcoholic drinks/week for women
- Use of nicotine, marijuana, or illicit drugs
- Pregnancy, planned pregnancy, or breastfeeding
- Inability to comprehend the nature of the study or instructions
- No access to the internet
- Planning to leave the Spokane area during the study
- Not fluent in the English language
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Ready-to-eat meals
Pre-Post
|
Participant group to consume ready-to-eat meals in accordance with the DASH diet for a period of 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure
Time Frame: through study completion, measured weekly for 5 weeks
|
To determine dietary patterns on blood pressure using an omron blood pressure monitor.
|
through study completion, measured weekly for 5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body weight (kg)
Time Frame: through study completion, measured weekly for 5 weeks
|
To determine dietary patterns on body weight (kg) using a Angel USA 400 Pound Physician Digital Scale.
|
through study completion, measured weekly for 5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Pablo Monsivais, PhD, MPH, Washington State University
- Principal Investigator: Martine M Perrigue, PhD, RDN, Washington State University
- Principal Investigator: Catherine Jarrett, PhD, RDN, Washington State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2022
Primary Completion (Actual)
May 1, 2023
Study Completion (Actual)
May 1, 2023
Study Registration Dates
First Submitted
July 15, 2022
First Submitted That Met QC Criteria
July 20, 2022
First Posted (Actual)
July 25, 2022
Study Record Updates
Last Update Posted (Actual)
June 3, 2026
Last Update Submitted That Met QC Criteria
June 1, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19288-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Ready-to-eat meals
-
University of Texas Southwestern Medical CenterCompletedCancer | Diet, Healthy | Nutrition, HealthyUnited States
-
University of Texas Southwestern Medical CenterCompletedDiet, Healthy | Food SecurityUnited States
-
National University Hospital, SingaporeRecruitingObesity | Overweight | Weight Loss | Ketogenic DietingSingapore
-
Harokopio UniversityCompletedDiabetes Mellitus, Type 2Greece
-
National University Hospital, SingaporeAlexandra HospitalRecruitingBariatric Surgery CandidateSingapore
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...CompletedDiabetes | Overweight | ConstipationBrazil
-
University of LeedsKellogg CompanyCompleted
-
Stoffwechselzentrum Rhein - PfalzRecruitingPregnancy Related | Insulin Sensitivity/Resistance | Gestational Diabetes | Glucose Tolerance Impaired | Glucose Tolerance Impaired in PregnancyGermany
-
Washington State UniversityUnited States Department of Agriculture (USDA)CompletedHealth Behavior | Diet, Healthy | Diet HabitUnited States